comparemela.com

Latest Breaking News On - சிங்கப்பூர் ஆரோக்கியம் அறிவியல் அதிகாரம் - Page 6 : comparemela.com

ADB Establishes High-Level Advisory Group for COVID-19 Vaccines

ADB Establishes High-Level Advisory Group for COVID-19 Vaccines
adb.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from adb.org Daily Mail and Mail on Sunday newspapers.

MOH, NCID expert counter claims by doctors on need to halt Covid-19 jabs for schoolboys

SINGAPORE - Singapore’s expert committee on Covid-19 vaccination and a senior infectious diseases specialist from the National Centre for Infectious Diseases (NCID) have come out to counter claims by a group of doctors behind an open letter arguing for a halt in the vaccination of young people here. In a revised statement issued on Monday (June 28), the Ministry of Health (MOH), which oversees the Expert Committee on Covid-19 Vaccination, said that news reports about a child s death in the United States did not state heart failure as a cause, as alleged in the open letter.  The matter is still under investigation by the US authorities, said MOH. 

GSK Singapore and Vir Biotechnology Announce Advance Purchase Agreement with the Government of Singapore for Monoclonal Antibody Sotrovimab (VIR-7831)

June 29, 2021 GSK Singapore has signed an Advance Purchase Agreement with the Government of Singapore for sotrovimab Sotrovimab is currently undergoing review by the Singapore Health Sciences Authority (HSA) under the Pandemic Special Access Route (PSAR) for interim authorization Announcement follows the emergency use authorization (EUA) granted to sotrovimab by the US Food and Drug Administration (FDA) and a positive scientific opinion by the European Medicines Agency s (EMA) Committee for Medicinal Products for Human Use (CHMP)   SINGAPORE, June 30, 2021 /PRNewswire/  GlaxoSmithKline Singapore and Vir Biotechnology announced an agreement with the Government of Singapore for the supply of sotrovimab, an investigational single-dose monoclonal antibody, for the treatment of patients with COVID-19 who do not require oxygen supplementation and who are at risk of progressing to severe COVID-19. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.